FDA is quietly preparing one of the most disruptive shifts in global early phase regulation: an optional clinical trial notification pathway that trades some traditional animal toxicology for validated nonanimal methods, aiming…
Read More
Every startup requires capital to fuel ambitious ideas. While funding catalyses progress, it is the experience of the team, the quality of the asset and the available data, along with…
Read More
